188 related articles for article (PubMed ID: 36438483)
1. TIMM44 is a potential therapeutic target of human glioma.
Guo YZ; Chen G; Huang M; Wang Y; Liu YY; Jiang Q; Cao C; Liu F
Theranostics; 2022; 12(17):7586-7602. PubMed ID: 36438483
[TBL] [Abstract][Full Text] [Related]
2. The mitochondrial protein TIMM44 is required for angiogenesis in vitro and in vivo.
Ma ZR; Li HP; Cai SZ; Du SY; Chen X; Yao J; Cao X; Zhen YF; Wang Q
Cell Death Dis; 2023 May; 14(5):307. PubMed ID: 37147302
[TBL] [Abstract][Full Text] [Related]
3. A first-in-class TIMM44 blocker inhibits bladder cancer cell growth.
Zhang L; Shi X; Zhang L; Mi Y; Zuo L; Gao S
Cell Death Dis; 2024 Mar; 15(3):204. PubMed ID: 38467612
[TBL] [Abstract][Full Text] [Related]
4. The mitochondrial protein YME1 Like 1 is important for non-small cell lung cancer cell growth.
Xia Y; He C; Hu Z; Wu Z; Hui Y; Liu YY; Mu C; Zha J
Int J Biol Sci; 2023; 19(6):1778-1790. PubMed ID: 37063426
[TBL] [Abstract][Full Text] [Related]
5. Targeting the mitochondrial protein YME1L to inhibit osteosarcoma cell growth in vitro and in vivo.
Sun X; Shi C; Dai J; Zhang MQ; Pei DS; Yang L
Cell Death Dis; 2024 May; 15(5):346. PubMed ID: 38769124
[TBL] [Abstract][Full Text] [Related]
6. Identification of the mitochondrial protein POLRMT as a potential therapeutic target of prostate cancer.
Li X; Yao L; Wang T; Gu X; Wu Y; Jiang T
Cell Death Dis; 2023 Oct; 14(10):665. PubMed ID: 37816734
[TBL] [Abstract][Full Text] [Related]
7. G protein inhibitory α subunit 2 is a molecular oncotarget of human glioma.
Wang Y; Liu F; Wu J; Zhang MQ; Chai JL; Cao C
Int J Biol Sci; 2023; 19(3):865-879. PubMed ID: 36778118
[TBL] [Abstract][Full Text] [Related]
8. ADCK1 is a potential therapeutic target of osteosarcoma.
Zhuo BB; Zhu LQ; Yao C; Wang XH; Li SX; Wang R; Li Y; Ling ZY
Cell Death Dis; 2022 Nov; 13(11):954. PubMed ID: 36371387
[TBL] [Abstract][Full Text] [Related]
9. Translocase of inner mitochondrial membrane 44 alters the mitochondrial fusion and fission dynamics and protects from type 2 diabetes.
Wang Y; Katayama A; Terami T; Han X; Nunoue T; Zhang D; Teshigawara S; Eguchi J; Nakatsuka A; Murakami K; Ogawa D; Furuta Y; Makino H; Wada J
Metabolism; 2015 Jun; 64(6):677-88. PubMed ID: 25749183
[TBL] [Abstract][Full Text] [Related]
10. The pro-tumorigenic activity of p38γ overexpression in nasopharyngeal carcinoma.
Yin DP; Zheng YF; Sun P; Yao MY; Xie LX; Dou XW; Tian Y; Liu JS
Cell Death Dis; 2022 Mar; 13(3):210. PubMed ID: 35246508
[TBL] [Abstract][Full Text] [Related]
11. HOXC13-driven TIMM13 overexpression promotes osteosarcoma cell growth.
Han Q; Yan P; Song R; Liu F; Tian Q
Cell Death Dis; 2023 Jul; 14(7):398. PubMed ID: 37407582
[TBL] [Abstract][Full Text] [Related]
12. Lnc-THOR silencing inhibits human glioma cell survival by activating MAGEA6-AMPK signaling.
Xue J; Zhong S; Sun BM; Sun QF; Hu LY; Pan SJ
Cell Death Dis; 2019 Nov; 10(11):866. PubMed ID: 31727877
[TBL] [Abstract][Full Text] [Related]
13. HuR Promotes Ovarian Cancer Cell Proliferation by Regulating TIMM44 mRNA Stability.
Yu X; Li Y; Ding Y; Zhang H; Ding N; Lu M
Cell Biochem Biophys; 2020 Dec; 78(4):447-453. PubMed ID: 32901414
[TBL] [Abstract][Full Text] [Related]
14. The mitochondrial RNA polymerase POLRMT promotes skin squamous cell carcinoma cell growth.
Wang Y; Ou L; Li X; Zheng T; Zhu WP; Li P; Wu L; Zhao T
Cell Death Discov; 2022 Aug; 8(1):347. PubMed ID: 35922422
[TBL] [Abstract][Full Text] [Related]
15. Circular RNA PRKCI promotes glioma cell progression by inhibiting microRNA-545.
Zhang X; Yang H; Zhao L; Li G; Duan Y
Cell Death Dis; 2019 Aug; 10(8):616. PubMed ID: 31409777
[TBL] [Abstract][Full Text] [Related]
16. Identification of Gαi3 as a novel molecular therapeutic target of cervical cancer.
Zhang J; Yin DP; Zhang Y; Zhang JN; Yang Y; Zhang ZQ; Zhou L; Lv Y; Huang HW; Cao C
Int J Biol Sci; 2022; 18(15):5667-5680. PubMed ID: 36263185
[TBL] [Abstract][Full Text] [Related]
17. Identification of Gαi3 as a promising target for osteosarcoma treatment.
Bian ZJ; Shan HJ; Zhu YR; Shi C; Chen MB; Huang YM; Wang XD; Zhou XZ; Cao C
Int J Biol Sci; 2022; 18(4):1508-1520. PubMed ID: 35280670
[TBL] [Abstract][Full Text] [Related]
18. The histone acetyltransferase HBO1 functions as a novel oncogenic gene in osteosarcoma.
Gao YY; Ling ZY; Zhu YR; Shi C; Wang Y; Zhang XY; Zhang ZQ; Jiang Q; Chen MB; Yang S; Cao C
Theranostics; 2021; 11(10):4599-4615. PubMed ID: 33754016
[TBL] [Abstract][Full Text] [Related]
19. A first-in-class POLRMT specific inhibitor IMT1 suppresses endometrial carcinoma cell growth.
Li SP; Ou L; Zhang Y; Shen FR; Chen YG
Cell Death Dis; 2023 Feb; 14(2):152. PubMed ID: 36823110
[TBL] [Abstract][Full Text] [Related]
20. Identification of the mitochondrial protein ADCK2 as a therapeutic oncotarget of NSCLC.
Zhang JZ; Liu J; Xu YX; Pu WY; Shen MJ; Jiang KQ; Yang YL; Lu J; Deng Z; Yang Y; Xu WH
Int J Biol Sci; 2022; 18(16):6163-6175. PubMed ID: 36439873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
